Hepatitis C Virus and the Humoral Immune System

Completed

Conditions studied: Hepatitis C Virus

In brief

The purpose of this study is to measure specific chemokines, antibodies, and antibody-producing B cells in the blood of patients with hepatitis C virus (HCV) infection. Our hypothesis is that changes in chemokine levels affect the development of an effective immune response against HCV.

Key facts

Study ID

NCT00219999

Run by

Rockefeller University

People needed

161

Starts

2001-09-01

Expected to finish

2013-05-01

Last updated by the study team

2013-08-09

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers, no liver disease
• Chronic infection with hepatitis C virus
• Other chronic liver disease unrelated to hepatitis C virus
• Subjects in all groups must have sufficiently healthy veins to allow blood collection.

You may not qualify if…

• Any medical condition that, in the opinion of the investigators, precludes the patient's participation

Where it is running

• Rockefeller University Hosital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.